Europe Schizophrenia Drugs Market Size & Outlook, 2025-2030
Related Markets
Europe schizophrenia drugs market highlights
- The Europe schizophrenia drugs market generated a revenue of USD 2,238.8 million in 2024.
- The market is expected to grow at a CAGR of 4.9% from 2025 to 2030.
- In terms of segment, second generation antipsychotics was the largest revenue generating class in 2024.
- Third Generation Antipsychotics is the most lucrative class segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 2,238.8 million |
| Market revenue in 2030 | USD 2,945.8 million |
| Growth rate | 4.9% (CAGR from 2025 to 2030) |
| Largest segment | Second generation antipsychotics |
| Fastest growing segment | Third Generation Antipsychotics |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Second Generation Antipsychotics, Third Generation Antipsychotics |
| Key market players worldwide | Johnson & Johnson, Bristol-Myers Squibb Co, AstraZeneca PLC, Sumitomo Dainippon Pharma Oncology, Eli Lilly and Co, Alkermes PLC, Allergan, Pfizer Inc, H. Lundbeck AS Class A |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.3% of the global schizophrenia drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,105.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Schizophrenia Drugs Market Scope
Schizophrenia Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alkermes PLC | View profile | 2100 | 1 Burlington Road, Connaught House, Dublin, Ireland, D04 C5Y6 | https://www.alkermes.com |
| Sumitomo Dainippon Pharma Oncology | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | https://www.sdponcology.com/ |
| H. Lundbeck AS Class A | View profile | 5700 | Ottiliavej 9, Valby, Denmark, 2500 | https://www.lundbeck.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | http://www.allergan.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Europe schizophrenia drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to schizophrenia drugs market will help companies and investors design strategic landscapes.
Second generation antipsychotics was the largest segment with a revenue share of 75.6% in 2024. Horizon Databook has segmented the Europe schizophrenia drugs market based on second generation antipsychotics, third generation antipsychotics covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Europe schizophrenia drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe schizophrenia drugs market databook
-
Our clientele includes a mix of schizophrenia drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe schizophrenia drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Europe schizophrenia drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe schizophrenia drugs market size, by country, 2018-2030 (US$M)
Europe Schizophrenia Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
